HER1–HER4 expression and co-expression in advanced urothelial carcinoma

ESMO Open·August 5Open Access

Oncology Urothelial Carcinoma HER Family Receptor Targeting Adult

Summary

What was studied

This study evaluated the expression and co-expression patterns of HER1–HER4 receptors in patients with advanced urothelial carcinoma, likely assessing prevalence and potential therapeutic relevance across the HER family.

Caveats

The paper metadata provides only the title, journal, DOI, and publication date — no abstract, methods, results, or conclusions were supplied. All structured fields requiring specific data (key result, sample size, limitations, study design, sex, level of evidence, practice takeaway) have been omitted to avoid speculation. A full-text source is needed for complete extraction.

HER1–HER4 expression and co-expression in advanced urothelial carcinoma

Summary

What was studied

Caveats

Related Questions

HER1–HER4 expression and co-expression in advanced urothelial carcinoma

Summary

What was studied

Caveats

Related Questions